4,4-Dimethyl-6-bromo-1,3-benzoxazine-2-one

CAS : 21440-97-1

Ref. 3D-FD11807

Informations sur le produit

• Nom: 4,4-Dimethyl-6-bromo-1,3-benzoxazine-2-one
• Synonymes: Brofoxine, 21440-97-1, 2H-3,1-Benzoxazin-2-one, 6-bromo-1,4-dihydro-4,4-dimethyl-, 6-Brom-4,4-dimethyl-1,4-dihydro-2H-3,1-benzoxazin-2-on, 6-Bromo-1,4-dihydro-4,4-dimethyl-2H-3,1-benzoxazin-2-one, 6-Bromo-4,4-dimethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one, 6-Bromo-4,4-dimethyl-1H-benzo[d][1,3]oxazin-2(4H)-one, Fi 6820

Description

4,4-Dimethyl-6-bromo-1,3-benzoxazine-2-one is a fatty acid ester that is reconstituted with an alcohol. It has been shown to be reactive in the presence of nucleophiles and can be used as a pharmaceutical preparation. 4,4-Dimethyl-6-bromo-1,3-benzoxazine-2-one has been found to cause insulin resistance in rats by increasing the expression of fatty acid synthase and inhibiting the activity of phosphatidylinositol 3 kinase. It also reduces the production of gamma aminobutyric acid (GABA) in humans. 4,4-Dimethyl-6-bromo-1,3 -benzoxazine 2 one has been shown to have antiinflammatory properties due to its inhibition of prostaglandin synthesis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 256.1 g/mol
• Formule: C₁₀H₁₀BrNO₂
• Degré de pureté: Min. 95%